(Q41782321)

9 October 2017

Cystic fibrosis. 7. Management of cystic fibrosis in different countries. Cystic fibrosis in Copenhagen (English)

1 reference

9 October 2017

0 references

Koch C

1

1 reference

9 October 2017

Høiby N

series ordinal

2

1 reference

9 October 2017

language of work or name

English

0 references

publication date

1 May 1991

1 reference

9 October 2017

1 reference

9 October 2017

46

1 reference

9 October 2017

5

1 reference

9 October 2017

385-6; discussion 389-90

1 reference

Antibiotic treatment of Staphylococcus aureus infection in cystic fibrosis

9 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1020973

Frequent antibiotic therapy improves survival of cystic fibrosis patients with chronic Pseudomonas aeruginosa infection

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1020973

Positive expiratory pressure (PEP-mask) physiotherapy improves ventilation and reduces volume of trapped gas in cystic fibrosis.

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1020973

The efficacy and safety of ciprofloxacin and ofloxacin in chronic Pseudomonas aeruginosa infection in cystic fibrosis.

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1020973

Management of Pseudomonas aeruginosa lung infection in Danish cystic fibrosis patients.

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1020973

Pathogenic mechanisms of chronic Pseudomonas aeruginosa infections in cystic fibrosis patients.

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1020973

Estimated risk of cross-infection with Pseudomonas aeruginosa in Danish cystic fibrosis patients.

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1020973

Relation between tumor necrosis factor-alpha and granulocyte elastase-alpha 1-proteinase inhibitor complexes in the plasma of patients with cystic fibrosis

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1020973

Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1020973

Improving the ketchup bottle method with positive expiratory pressure, PEP, in cystic fibrosis

6 June 2018

1 reference

12 December 2020

Nebulised colomycin for early pseudomonas colonisation in cystic fibrosis

1 reference

12 December 2020

Frequency of Aspergillus fumigatus isolates and antibodies to aspergillus antigens in cystic fibrosis

1 reference

12 December 2020

Colistin inhalation therapy in cystic fibrosis patients with chronic Pseudomonas aeruginosa lung infection

1 reference

12 December 2020

Diabetes mellitus associated with cystic fibrosis

1 reference

12 December 2020

Clinical and serological survey of pulmonary aspergillosis in patients with cystic fibrosis

1 reference

12 December 2020

A comparison of survival, growth, and pulmonary function in patients with cystic fibrosis in Boston and Toronto

1 reference

12 December 2020

Identifiers

DOI

10.1136/THX.46.5.385

1 reference

9 October 2017

1 reference

9 October 2017

PubMed publication ID

2068698

1 reference